<DOC>
	<DOC>NCT01198795</DOC>
	<brief_summary>This study will evaluate the long-term safety and tolerability of escitalopram (Lexapro) in children 7 to 11 years of age with major depressive disorder (MDD).</brief_summary>
	<brief_title>Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Male or female outpatients 7 to 11 years of age, inclusive Current diagnosis of MDD based on DSMIVTR (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision) criteria as confirmed by KSADSPL (Kiddie Schedule for Affective Disorders and SchizophreniaPresent and Lifetime) with a minimum duration of 6 weeks Patient's parent(s), guardian(s), or LAR(s) is capable of providing information about his or her condition, provides informed consent, and agrees to accompany the patient to all study visits. (Preferably the same parent, guardian, or LAR will accompany the patient to all study visits) Patient's family is sufficiently organized and stable to guarantee adequate safety monitoring Current principal DSMIVTRbased diagnosis of an axis I disorder other than MDD that was the primary focus of treatment Patients with a diagnosis of conduct disorder will not be allowed to participate in this study Current diagnosis of mental retardation, dementia, or amnestic or other cognitive disorders based on DSMIVTR criteria History of allergy, intolerance, or hypersensitivity to escitalopram, citalopram, or other drugs of the same class Imminent risk of injuring self or others or causing significant damage to property, as judged by the PI Suicide risk as determined by meeting any of the following criteria: Any suicide attempt Significant risk, as judged by the PI, based on the psychiatric interview or information collected in the ColumbiaSuicide Severity Rating Scale (CSSRS)</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>depression</keyword>
	<keyword>major depressive disorder</keyword>
	<keyword>escitalopram</keyword>
	<keyword>Lexapro</keyword>
	<keyword>pediatric</keyword>
</DOC>